Literatur
Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90.056 participants in 14 randomised trials of statins. Lancet 366:1267–1278
Cannon CP, Blazing MA, Giugliano RP et al (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372:2387–2397
Stone NJ, Robinson JG, Lichtenstein AH et al (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 129:1–45
Windecker S, Kolh P et al (2014) ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619
Jarcho JA, Keaney JF, Jr. (2015) Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT. N Engl J Med 372:2448–2450
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Özcelik und M. Gailani geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Özcelik, C., Gailani, M. IMPROVE-IT-Studie. Kardiologe 9, 329–331 (2015). https://doi.org/10.1007/s12181-015-0019-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-015-0019-3